Literature DB >> 24974106

Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.

Angela K Shen1, Marguerite M Farrell2, Mary F Vandenbroucke2, Elizabeth Fox2, Ariel Pablos-Mendez2.   

Abstract

As low income countries experience economic transition, characterized by rapid economic growth and increased government spending potential in health, they have increased fiscal space to support and sustain more of their own health programmes, decreasing need for donor development assistance. Phase out of external funds should be systematic and efforts towards this end should concentrate on government commitments towards country ownership and self-sustainability. The 2006 US Agency for International Development (USAID) family planning (FP) graduation strategy is one such example of a systematic phase-out approach. Triggers for graduation were based on pre-determined criteria and programme indicators. In 2011 the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunizations) which primarily supports financing of new vaccines, established a graduation policy process. Countries whose gross national income per capita exceeds $1570 incrementally increase their co-financing of new vaccines over a 5-year period until they are no longer eligible to apply for new GAVI funding, although previously awarded support will continue. This article compares and contrasts the USAID and GAVI processes to apply lessons learned from the USAID FP graduation experience to the GAVI process. The findings of the review are 3-fold: (1) FP graduation plans served an important purpose by focusing on strategic needs across six graduation plan foci, facilitating graduation with pre-determined financial and technical benchmarks, (2) USAID sought to assure contraceptive security prior to graduation, phasing out of contraceptive donations first before phasing out from technical assistance in other programme areas and (3) USAID sought to sustain political support to assure financing of products and programmes continue after graduation. Improving sustainability more broadly beyond vaccine financing provides a more comprehensive approach to graduation. The USAID FP experience provides a window into understanding one approach to graduation from donor assistance. The process itself-involving transparent country-level partners well in advance of graduation-appears a valuable lesson towards success. Published by Oxford University Press 2014. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  GAVI; USAID; family planning graduation; immunization; vaccine

Mesh:

Substances:

Year:  2014        PMID: 24974106     DOI: 10.1093/heapol/czu045

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  10 in total

1.  Effects of transition on HIV and non-HIV services and health systems in Kenya: a mixed methods evaluation of donor transition.

Authors:  Daniela C Rodríguez; Diwakar Mohan; Caroline Mackenzie; Jess Wilhelm; Ezinne Eze-Ajoku; Elizabeth Omondi; Mary Qiu; Sara Bennett
Journal:  BMC Health Serv Res       Date:  2021-05-13       Impact factor: 2.655

2.  The future of routine immunization in the developing world: challenges and opportunities.

Authors:  Angela K Shen; Rebecca Fields; Mike McQuestion
Journal:  Glob Health Sci Pract       Date:  2014-12-10

3.  Scaling Up and Sustaining Voluntary Medical Male Circumcision: Maintaining HIV Prevention Benefits.

Authors:  Emmanuel Njeuhmeli; Marelize Gorgens; Elizabeth Gold; Rachel Sanders; Jackson Lija; Alice Christensen; Francis Ndwiga Benson; Elizabeth Mziray; Kim Seifert Ahanda; Deborah Kaliel; Tin Tin Sint; Chewe Luo
Journal:  Glob Health Sci Pract       Date:  2016-07-13

4.  Monitoring and Evaluating the Transition of Large-Scale Programs in Global Health.

Authors:  James Bao; Daniela C Rodriguez; Ligia Paina; Sachiko Ozawa; Sara Bennett
Journal:  Glob Health Sci Pract       Date:  2015-12-17

5.  The Avahan Transition: Effects of Transition Readiness on Program Institutionalization and Sustained Outcomes.

Authors:  Sachiko Ozawa; Suneeta Singh; Kriti Singh; Vibha Chhabra; Sara Bennett
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

6.  Political commitment for vulnerable populations during donor transition.

Authors:  Daniela C Rodríguez; Alan Whiteside; Sara Bennett
Journal:  Bull World Health Organ       Date:  2017-02-01       Impact factor: 9.408

7.  The Challenges of Transition From Donor-Funded Programs: Results From a Theory-Driven Multi-Country Comparative Case Study of Programs in Eastern Europe and Central Asia Supported by the Global Fund.

Authors:  George Gotsadze; Ivdity Chikovani; Lela Sulaberidze; Tamar Gotsadze; Ketevan Goguadze; Nertila Tavanxhi
Journal:  Glob Health Sci Pract       Date:  2019-06-27

8.  Health priority-setting for official development assistance in low-income and middle-income countries: a Best Fit Framework Synthesis study with primary data from Ethiopia, Nigeria and Tanzania.

Authors:  Rifat Atun; Wafaie Fawzi; Xiaoxiao Jiang Kwete; Yemane Berhane; Mary Mwanyika-Sando; Ayo Oduola; Yuning Liu; Firehiwot Workneh; Smret Hagos; Japhet Killewo; Dominic Mosha; Angela Chukwu; Kabiru Salami; Bidemi Yusuf; Kun Tang; Zhi-Jie Zheng
Journal:  BMC Public Health       Date:  2021-11-21       Impact factor: 3.295

Review 9.  The impacts of donor transitions on health systems in middle-income countries: a scoping review.

Authors:  Hanna E Huffstetler; Shashika Bandara; Ipchita Bharali; Kaci Kennedy Mcdade; Wenhui Mao; Felicia Guo; Jiaqi Zhang; Judy Riviere; Liza Becker; Mina Mohamadi; Rebecca L Rice; Zoe King; Zoha Waqar Farooqi; Xinqi Zhang; Gavin Yamey; Osondu Ogbuoji
Journal:  Health Policy Plan       Date:  2022-10-12       Impact factor: 3.547

10.  Family Planning in the Context of Latin America's Universal Health Coverage Agenda.

Authors:  Thomas Fagan; Arin Dutta; James Rosen; Agathe Olivetti; Kate Klein
Journal:  Glob Health Sci Pract       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.